Tapewire

Nasdaq · USD

ZVRA

ZEVRA THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
5212
SEC CIK
0001434647
Parsed reports
261

Last 12 months

Inside the activity.

0 purchase rows · 13 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202604
Feb 202604
Mar 202600
Apr 202600
May 202601
Jun 202601
Jul 202600
Aug 202602
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 29, 2026 Filed Feb 2, 2026 22:19 UTC
Quartel Adrian WChief Medical Officer
GrantStock Option (right to buy) · Derivative 75,000 $0.00 Strike: $8.86 $0.00
Disclosure

SEC source: 0001910132-26-000002 · wk-form4_1770070750.xml · derivative · entry 4

Quartel Adrian W · CIK 0001910132 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2036-01-28

F5 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
January 29, 2026 Filed Feb 2, 2026 22:19 UTC
Quartel Adrian WChief Medical Officer
GrantRestricted Stock Unit · Derivative 37,500 $0.00 $0.00
Disclosure

SEC source: 0001910132-26-000002 · wk-form4_1770070750.xml · derivative · entry 3

Quartel Adrian W · CIK 0001910132 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

Read SEC document
January 29, 2026 Filed Feb 2, 2026 22:19 UTC GrantStock Option (right to buy) · Derivative 75,000 $0.00 Strike: $8.86 $0.00
Disclosure

SEC source: 0001945557-26-000002 · wk-form4_1770070744.xml · derivative · entry 5

Schafer Joshua · CIK 0001945557 · CCO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2036-01-28

F5 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
January 29, 2026 Filed Feb 2, 2026 22:19 UTC GrantRestricted Stock Unit · Derivative 37,500 $0.00 $0.00
Disclosure

SEC source: 0001945557-26-000002 · wk-form4_1770070744.xml · derivative · entry 4

Schafer Joshua · CIK 0001945557 · CCO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

Read SEC document
January 29, 2026 Filed Feb 2, 2026 22:18 UTC
McFarlane Neil F.Director · President and CEO
GrantStock Option (right to buy) · Derivative 250,000 $0.00 Strike: $8.86 $0.00
Disclosure

SEC source: 0001681098-26-000002 · wk-form4_1770070730.xml · derivative · entry 4

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2036-01-28

F5 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
January 29, 2026 Filed Feb 2, 2026 22:18 UTC
McFarlane Neil F.Director · President and CEO
GrantRestricted Stock Unit · Derivative 125,000 $0.00 $0.00
Disclosure

SEC source: 0001681098-26-000002 · wk-form4_1770070730.xml · derivative · entry 3

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

Read SEC document
December 31, 2025 Filed Jan 7, 2026 16:18 UTC
Clifton R. LaDuaneFormer CFO & Treasurer
Exercise / conversionPerformance Stock Unit · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001488774-26-000002 · wk-form4_1767820678.xml · derivative · entry 5

Clifton R. LaDuane · CIK 0001488774 · Former CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.

F4 · derivative.expiration_date: The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.

Read SEC document
December 31, 2025 Filed Jan 7, 2026 16:18 UTC
Clifton R. LaDuaneFormer CFO & Treasurer
Exercise / conversionRestricted Stock Unit · Derivative 34,000 $0.00 $0.00
Disclosure

SEC source: 0001488774-26-000002 · wk-form4_1767820678.xml · derivative · entry 4

Clifton R. LaDuane · CIK 0001488774 · Former CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 34,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.

F4 · derivative.expiration_date: The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.

Read SEC document
December 31, 2025 Filed Jan 7, 2026 16:18 UTC
Clifton R. LaDuaneFormer CFO & Treasurer
Exercise / conversionRestricted Stock Unit · Derivative 86,667 $0.00 $0.00
Disclosure

SEC source: 0001488774-26-000002 · wk-form4_1767820678.xml · derivative · entry 3

Clifton R. LaDuane · CIK 0001488774 · Former CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 86,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.

F4 · derivative.expiration_date: The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.

Read SEC document
December 31, 2025 Filed Jan 7, 2026 16:18 UTC
Clifton R. LaDuaneFormer CFO & Treasurer
Tax withholdingCommon Stock 48,513 $8.96 $434,676.48
Disclosure

SEC source: 0001488774-26-000002 · wk-form4_1767820678.xml · nonDerivative · entry 2

Clifton R. LaDuane · CIK 0001488774 · Former CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,515

F2 · shares: Shares withheld to cover withholding taxes for the vested restricted stock units and performance stock units.

Read SEC document
December 31, 2025 Filed Jan 7, 2026 16:18 UTC
Clifton R. LaDuaneFormer CFO & Treasurer
Exercise / conversionCommon Stock 140,667 $0.00 $0.00
Disclosure

SEC source: 0001488774-26-000002 · wk-form4_1767820678.xml · nonDerivative · entry 1

Clifton R. LaDuane · CIK 0001488774 · Former CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,028

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares issued upon vesting of restricted stock units and performance stock units on December 31, 2025.

Read SEC document
December 02, 2025 Filed Dec 9, 2025 21:18 UTC
Secor AliciaDirector
GrantStock Option (right to buy) · Derivative 45,000 $0.00 Strike: $8.17 $0.00
Disclosure

SEC source: 0001584516-25-000009 · wk-form4_1765315079.xml · derivative · entry 1

Secor Alicia · CIK 0001584516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2035-12-01

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, December 2, 2025.

F2 · derivative.exercise_date: The option will vest and become exercisable as follows: (1) in three equal installments on the each of the dates that are one day prior to the first three annual stockholder meetings occurring after the grant date, or (2) immediately prior to a Change in Control, subject in each case to the director's continued service on such vesting date.

Read SEC document
October 10, 2025 Filed Oct 10, 2025 23:17 UTC
McFarlane Neil F.Director · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 50,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001681098-25-000005 · wk-form4_1760138252.xml · derivative · entry 3

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: 25% of the RSUs vested and settled on each of October 10, 2024 and October 10, 2025. The remaining 50% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates the Reporting Person's employment relationship has not been terminated as defined in the Issuer's 2023 Employment Inducement Award Plan. All shares will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason.

F3 · derivative.expiration_date: 25% of the RSUs vested and settled on each of October 10, 2024 and October 10, 2025. The remaining 50% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates the Reporting Person's employment relationship has not been terminated as defined in the Issuer's 2023 Employment Inducement Award Plan. All shares will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason.

Read SEC document
October 10, 2025 Filed Oct 10, 2025 23:17 UTC
McFarlane Neil F.Director · President and CEO
SaleCommon Stock 19,500 $10.82 $210,908.10
Disclosure

SEC source: 0001681098-25-000005 · wk-form4_1760138252.xml · nonDerivative · entry 2

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,016

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 03-21-2025.

Read SEC document
October 10, 2025 Filed Oct 10, 2025 23:17 UTC
McFarlane Neil F.Director · President and CEO
Exercise / conversionCommon Stock 50,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001681098-25-000005 · wk-form4_1760138252.xml · nonDerivative · entry 1

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 241,516

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
September 12, 2025 Filed Sep 15, 2025 20:07 UTC
Shih AlvinDirector
PurchaseCommon Stock 20,000 $7.89 $157,800.00
Disclosure

SEC source: 0001610064-25-000011 · wk-form4_1757966847.xml · nonDerivative · entry 1

Shih Alvin · CIK 0001610064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.85 to $7.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
September 12, 2025 Filed Sep 16, 2025 20:15 UTC PurchaseCommon Stock 3,175 $7.79 $24,718.01
Disclosure

SEC source: 0001288232-25-000009 · wk-form4_1758053735.xml · nonDerivative · entry 1

FAVORITO TAMARA A · CIK 0001288232 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,894

Read SEC document
August 19, 2025 Filed Aug 20, 2025 20:38 UTC
Bode John BDirector
PurchaseCommon Stock 5,000 $9.17 $45,825.00
Disclosure

SEC source: 0001437749-25-027456 · rdgdoc.xml · nonDerivative · entry 1

Bode John B · CIK 0001612084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Read SEC document
June 26, 2025 Filed Jun 30, 2025 21:02 UTC
Thompson RahsaanChief Legal & Compliance · Secretary
SaleCommon Stock 24,000 $9.21 $221,004.00
Disclosure

SEC source: 0001437749-25-021577 · rdgdoc.xml · nonDerivative · entry 1

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,666

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 03-27-2025

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.11 to $9.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
June 21, 2025 Filed Jun 24, 2025 21:28 UTC
Thompson RahsaanChief Legal & Compliance · Secretary
Exercise / conversionRestricted Stock Unit · Derivative 66,666 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-021183 · rdgdoc.xml · derivative · entry 2

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,334

Underlying: Common Stock · 66,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The first tranche of the restricted stock units vested and settled on June 21, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

F2 · derivative.expiration_date: The first tranche of the restricted stock units vested and settled on June 21, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Read SEC document
June 21, 2025 Filed Jun 24, 2025 21:28 UTC
Thompson RahsaanChief Legal & Compliance · Secretary
Exercise / conversionCommon Stock 66,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-25-021183 · rdgdoc.xml · nonDerivative · entry 1

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed May 31, 2025 01:38 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001437749-25-019046 · rdgdoc.xml · derivative · entry 1

Watton Corey Michael · CIK 0001975404 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2035-05-28

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
May 29, 2025 Filed May 31, 2025 01:38 UTC
Bode John BDirector
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001437749-25-019045 · rdgdoc.xml · derivative · entry 1

Bode John B · CIK 0001612084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2035-05-28

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
May 29, 2025 Filed May 31, 2025 01:41 UTC
Shih AlvinDirector
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001437749-25-019050 · rdgdoc.xml · derivative · entry 1

Shih Alvin · CIK 0001610064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2035-05-28

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
May 29, 2025 Filed May 31, 2025 01:40 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001437749-25-019049 · rdgdoc.xml · derivative · entry 1

DIXON WENDY L · CIK 0001202283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2035-05-28

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
May 29, 2025 Filed May 31, 2025 01:39 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001437749-25-019048 · rdgdoc.xml · derivative · entry 1

Calder Douglas W · CIK 0001510445 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2035-05-28

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
May 29, 2025 Filed May 31, 2025 01:39 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001437749-25-019047 · rdgdoc.xml · derivative · entry 1

FAVORITO TAMARA A · CIK 0001288232 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2035-05-28

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
May 29, 2025 Filed May 31, 2025 01:37 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001437749-25-019044 · rdgdoc.xml · derivative · entry 1

Anderson Thomas · CIK 0001612903 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2035-05-28

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
March 28, 2025 Filed Apr 1, 2025 00:05 UTC PurchaseCommon Stock 300 $7.84 $2,351.52
Disclosure

SEC source: 0001437749-25-010332 · rdgdoc.xml · nonDerivative · entry 1

Watton Corey Michael · CIK 0001975404 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

Read SEC document
March 19, 2025 Filed Mar 21, 2025 20:06 UTC
Bode John BDirector
PurchaseCommon Stock 10,000 $7.96 $79,624.00
Disclosure

SEC source: 0001437749-25-008738 · rdgdoc.xml · nonDerivative · entry 1

Bode John B · CIK 0001612084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
February 14, 2025 Filed Feb 14, 2025 22:54 UTC
McFarlane Neil F.Director · President and CEO
SaleCommon Stock 30,544 $8.05 $245,961.67
Disclosure

SEC source: 0001437749-25-004067 · rdgdoc.xml · nonDerivative · entry 2

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 191,516

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 10-15-2024

Read SEC document
February 13, 2025 Filed Feb 14, 2025 17:55 UTC
Clifton R. LaDuaneCFO & Treasurer
SaleCommon Stock 11,000 $7.86 $86,471.00
Disclosure

SEC source: 0001437749-25-004068 · rdgdoc.xml · nonDerivative · entry 1

Clifton R. LaDuane · CIK 0001488774 · CFO & Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,361

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 10/15/2024

Read SEC document
February 13, 2025 Filed Feb 14, 2025 22:55 UTC
Schafer JoshuaCCO & EVP, Bus. Development
SaleCommon Stock 10,500 $7.86 $82,526.85
Disclosure

SEC source: 0001437749-25-004069 · rdgdoc.xml · nonDerivative · entry 1

Schafer Joshua · CIK 0001945557 · CCO & EVP, Bus. Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,486

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 10/15/2024

Read SEC document
February 13, 2025 Filed Feb 14, 2025 22:57 UTC
Sangiovanni Timothy J.SVP, Finance & Corp Controller
SaleCommon Stock 3,000 $7.86 $23,587.80
Disclosure

SEC source: 0001437749-25-004070 · rdgdoc.xml · nonDerivative · entry 1

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,341

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 10-15-2024

Read SEC document
February 13, 2025 Filed Feb 14, 2025 22:54 UTC
McFarlane Neil F.Director · President and CEO
SaleCommon Stock 61,273 $7.86 $481,428.09
Disclosure

SEC source: 0001437749-25-004067 · rdgdoc.xml · nonDerivative · entry 1

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,060

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 10-15-2024

Read SEC document
February 07, 2025 Filed Feb 10, 2025 22:37 UTC
McFarlane Neil F.Director · President and CEO
GrantRestricted Stock Unit · Derivative 112,500 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-003328 · rdgdoc.xml · derivative · entry 2

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,500

Underlying: Common Stock · 112,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on February 7, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date.

F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on February 7, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Read SEC document
February 07, 2025 Filed Feb 10, 2025 22:37 UTC
McFarlane Neil F.Director · President and CEO
GrantStock Option (right to buy) · Derivative 225,000 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001437749-25-003328 · rdgdoc.xml · derivative · entry 1

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2035-02-06

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
January 31, 2025 Filed Feb 3, 2025 17:20 UTC
Clifton R. LaDuaneCFO & Treasurer
Exercise / conversionRestricted Stock Unit · Derivative 43,333 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-002625 · rdgdoc.xml · derivative · entry 2

Clifton R. LaDuane · CIK 0001488774 · CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,667

Underlying: Common Stock · 43,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

F2 · derivative.expiration_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Read SEC document
January 31, 2025 Filed Feb 3, 2025 17:20 UTC
Clifton R. LaDuaneCFO & Treasurer
Exercise / conversionCommon Stock 43,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-25-002625 · rdgdoc.xml · nonDerivative · entry 1

Clifton R. LaDuane · CIK 0001488774 · CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,361

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 31, 2025 Filed Feb 3, 2025 22:24 UTC
Sangiovanni Timothy J.SVP, Finance & Corp Controller
Exercise / conversionRestricted Stock Unit · Derivative 11,666 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-002629 · rdgdoc.xml · derivative · entry 2

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,334

Underlying: Common Stock · 11,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

F2 · derivative.expiration_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Read SEC document
January 31, 2025 Filed Feb 3, 2025 22:24 UTC
Sangiovanni Timothy J.SVP, Finance & Corp Controller
Exercise / conversionCommon Stock 11,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-25-002629 · rdgdoc.xml · nonDerivative · entry 1

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,341

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 31, 2025 Filed Feb 3, 2025 22:22 UTC
Schafer JoshuaCCO & EVP, Bus. Development
Exercise / conversionRestricted Stock Unit · Derivative 35,333 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-002627 · rdgdoc.xml · derivative · entry 2

Schafer Joshua · CIK 0001945557 · CCO & EVP, Bus. Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,667

Underlying: Common Stock · 35,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

F2 · derivative.expiration_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Read SEC document
January 31, 2025 Filed Feb 3, 2025 22:22 UTC
Schafer JoshuaCCO & EVP, Bus. Development
Exercise / conversionCommon Stock 35,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-25-002627 · rdgdoc.xml · nonDerivative · entry 1

Schafer Joshua · CIK 0001945557 · CCO & EVP, Bus. Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,986

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 31, 2025 Filed Feb 3, 2025 22:19 UTC
McFarlane Neil F.Director · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 233,333 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-002623 · rdgdoc.xml · derivative · entry 2

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 466,667

Underlying: Common Stock · 233,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

F2 · derivative.expiration_date: The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Read SEC document
January 31, 2025 Filed Feb 3, 2025 22:19 UTC
McFarlane Neil F.Director · President and CEO
Exercise / conversionCommon Stock 233,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-25-002623 · rdgdoc.xml · nonDerivative · entry 1

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 283,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 30, 2025 Filed Feb 3, 2025 17:20 UTC
Clifton R. LaDuaneCFO & Treasurer
GrantRestricted Stock Unit · Derivative 34,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-002625 · rdgdoc.xml · derivative · entry 4

Clifton R. LaDuane · CIK 0001488774 · CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,000

Underlying: Common Stock · 34,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Read SEC document
January 30, 2025 Filed Feb 3, 2025 17:20 UTC
Clifton R. LaDuaneCFO & Treasurer
GrantStock Option (right to buy) · Derivative 68,000 $0.00 Strike: $8.02 $0.00
Disclosure

SEC source: 0001437749-25-002625 · rdgdoc.xml · derivative · entry 3

Clifton R. LaDuane · CIK 0001488774 · CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,000

Underlying: Common Stock · 68,000 shares

Expires 2035-01-29

F3 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
January 30, 2025 Filed Feb 3, 2025 22:23 UTC
Thompson RahsaanChief Legal & Compliance · Secretary
GrantRestricted Stock Unit · Derivative 34,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-002628 · rdgdoc.xml · derivative · entry 2

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,000

Underlying: Common Stock · 34,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date.

F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Read SEC document
January 30, 2025 Filed Feb 3, 2025 22:23 UTC
Thompson RahsaanChief Legal & Compliance · Secretary
GrantStock Option (right to buy) · Derivative 68,000 $0.00 Strike: $8.02 $0.00
Disclosure

SEC source: 0001437749-25-002628 · rdgdoc.xml · derivative · entry 1

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,000

Underlying: Common Stock · 68,000 shares

Expires 2035-01-29

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
January 30, 2025 Filed Feb 3, 2025 22:24 UTC
Sangiovanni Timothy J.SVP, Finance & Corp Controller
GrantRestricted Stock Unit · Derivative 19,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-002629 · rdgdoc.xml · derivative · entry 4

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.